Enhanced oxidative stress and accelerated cellular senescence in glucose-6-phosphate dehydrogenase (G6PD)-deficient human fibroblasts

Free Radical Biology and Medicine

Volumn 29, Issue 2, 2000, Pages 156-169

  Ho, Hung Yao ^a,b   Cheng, Mei Ling ^c,d   Lu, Fung Jou ^d   Chou, Yi Hung ^e   Stern, Arnold ^f   Liang, Chi Ming ^a,b   Chiu, Daniel Tsun Yee ^c  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^f NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cell growth; Cell senescence; Free radicals; Glucose 6 phosphate dehydrogenase (G6PD); Oxidative stress

Indexed keywords

BETA GALACTOSIDASE; FLUORESCEIN; FREE RADICAL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ARTICLE; CELL AGING; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; HUMAN CELL; MALE; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; SKIN FIBROBLAST;

BETA-GALACTOSIDASE; CELL AGING; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; FIBROBLASTS; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; INFANT, NEWBORN; KINETICS; MALE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REFERENCE VALUES; SKIN; SKIN PHYSIOLOGY; TELOMERE; TRANSFECTION;

EID: 0034661010     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00331-2     Document Type: Article

References (47)

1. Luzzatto L., Battistuzzi G. Glucose-6-phosphate dehydrogenase. Adv. Hum. Genet. 14:1985;217-229.
2. Beutler E. The genetics of glucose-6-phosphate dehydrogenase deficiency. Semin. Hematol. 27:1990;137-164.
3. Beutler E. Glucose-6-phosphate dehydrogenase deficiency. New Engl. J. Med. 324:1991;169-174.
4. Scott M.D., Zuo L., Lubin B.H., Chiu D.T.Y. NADPH, not glutathione, status modulates oxidant sensitivity in normal and glucose-6-phosphate dehydrogenase-deficient erythrocytes. Blood. 77:1991;2059-2064.
5. Liu T.Z., Lin T.F., Hung I.J., Wei J.S., Chiu D.T.Y. Enhanced susceptibility of erythrocytes deficient in glucose-6-phosphate dehydrogenase to alloxan/glutathione-induced decrease in red cell deformability. Life Sci. 55:1994;55-60.
6. Johnson F.B., Sinclair D.A., Guarente L. Molecular biology of aging. Cell. 96:1999;291-302.
7. Beckman, K. B.; Ames, B. N. Oxidants, antioxidants and aging. In: Scandalios, J. G., ed. Oxidative stress, and the molecular biology of antioxidant defenses. New York: Cold Spring Harbor Laboratory Press; 1997:201-272.
8. Levine, R. L.; Stadtman, E. R. Protein modifications with aging. In: Schneider, E. L.; Rowe, J. W., eds. Handbook of the biology of aging. New York: Academic Press; 1996:184-197.
9. Randerath, K.; Randerath, E.; Filburn, C. Genomic and mitochondrial DNA alterations with aging. In: Schneider, E. L.; Rowe, J. W., eds. Handbook of the biology of aging. New York: Academic Press; 1996:198-214.
10. Orr W.C., Sohal R.S. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science. 263:1994;1128-1130.
11. Sun J.T., Tower J. FLP-recombinase-mediated induction of Cu/Zn superoxide dismutase transgene expression can extend the life span of adult Drosophila melanogaster flies. Mol. Cell. Biol. 19:1999;216-228.
12. Parkes T.L., Elia A.J., Dickinson D., Hilliker A.J., Philips J.P., Boulianne G.L. Extension of Drosophila lifespan by overexpression of human SOD1 in motorneurons. Nat. Genet. 19:1998;171-174.
13. Pandolfi P.P., Sonati F., Rivi R., Mason P., Grosveld F., Luzzatto L. Targeted disruption of the housekeeping gene encoding glucose-6-phosphate dehydrogenase (G6PD) G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress . EMBO J. 14:1995;5209-5215.
14. Freshney R.I. Disaggregation of the tissue and primary culture. Freshney R.I. Culture of animal cells. 1994;127-148 John Wiley & Sons, New York.
15. Chiu D.T.Y., Zuo L., Chen E., Chao L., Louie E., Lubin B., Liu T.Z., Du C.S. Two commonly occurring nucleotide base substitutions in Chinese G6PD variants. Biochem. Biophys. Res. Commun. 180:1991;988-993.
16. Chiu D.T.Y., Zuo L., Chao L., Chen E., Louie E., Lubin B., Liu T.Z., Du C.S. Molecular characterization of glucose-6-phosphate dehydro-genase deficiency in patients of Chinese descent and identification of new base substitution in the human G6PD gene. Blood. 81:1993;2150-2154.
17. Stevans D.J., Wanachiwanawin W., Mason P.J., Vulliamy T.J., Luzzatto L. G6PD Canton a common deficient variant in South East Asia caused by a 459 Arg→Leu mutation. Nucleic Acids Res. 18:1990;7190.
18. Bautista J.M., Mason P.J., Luzzatto L. Purification and properties of human glucose-6-phosphate dehydrogenase made in. E. coli. Biochem. Biophys. Acta. 119:1992;74-80.
19. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E.E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., Campisi J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;9363-9367.
20. + binding . Blood. 90:(Suppl.):1997;21I.
21. Pear, W. Transient transfection methods for preparation of high-titer retroviral supernatants. In: Ausubel, F. M.; Brent, R.; Kingston, R. E.; Moore, D. D.; Seidman, J. G.; Struhl, K., eds. Current protocols in molecular biology. New York: Greene Publishing Associates and Wiley-Interscience; 1996:9.11.1-9.11.18.
22. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during aging of human fibroblasts. Nature. 345:1990;458-460.
23. Bryan T.M., Englezou A., Gupta J., Bacchetti S., Reddel R.R. Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14:1995;4240-4248.
24. 2 in cultured endothelial cells. Arch. Biochem. Biophys. 302:1993;348-355.
25. Wright W.E., Shay J.W. Time, telomeres and tumours is cellular senescence more than an anticancer mechanism? Trends Cell Biol. 5:1995;293-297.
26. Gilchrest B.A., Bohr V.A. Aging processes, DNA damage, and repair. FASEB J. 11:1997;322-330.
27. Chang J.G., Chiou S.S., Perng L.I., Chen T.C., Liu T.C., Lee L.S., Chen P.H., Tang T.K. Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency by natural and amplification created restriction sites five mutations account for most G6PD deficiency cases in Taiwan . Blood. 80:1992;1079-1082.
28. Huang C.S., Hung K.L., Huang M.J., Li Y.C., Liu T.H., Tang T.K. Neonatal jaundice and molecular mutations in glucose-6-phosphate dehydrogenase deficient newborn infants. Am. J. Hematol. 51:1996;19-25.
29. Hayflick L., Moorhead P.S. The serial cultivation of human diploid cell strains. Exp. Cell Res. 25:1961;585-621.
30. Papaconstantinou, J.; Reisener, P. D.; Liu, L.; Kuninger, D. T. Mechanisms of altered gene expression with aging. In: Schneider, E. L.; Rowe, J. W., eds. Handbook of the biology of aging. New York: Academic Press; 1996:150-183.
31. 1 arrest in senescent human fibroblasts. Bioessay. 17:1995;537-543.
32. Chang Z.F. Regulatory mechanisms of replication growth limits in cellular senescence. J. Formos. Med. Assoc. 96:1997;784-791.
33. Stein G.H., Drullinger L.F., Soulard A., Dulic V. Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts. Mol. Cell. Biol. 19:1999;2109-2117.
34. Alcorta D.A., Xiong Y., Phelps D., Hannon G., Beach D., Barrett J.C. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc. Natl. Acad Sci. USA. 93:1996;13742-13747.
35. INK4a. Cell. 88:1997;593-602.
36. 1/S cell cycle mediators in cellular senescence. Exp. Cell Res. 209:1993;231-237.
37. Lin A.W., Barradas M., Stone J.C., Aelst L., Serrano M., Lowe S.W. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:1998;3008-3019.
38. Sugrue M.M., Shin D.Y., Lee S.W., Aaronson S.A. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc. Natl. Acad. Sci. USA. 94:1997;9648-9653.
39. Zhu J., Woods D., McMahon M., Bishop M. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:1998;2997-3007.
40. Holliday R. Strong effects of 5-azacytidine on the in vitro lifespan of human fibroblasts. Exp. Cell Res. 166:1986;543-552.
41. Fairweather D.S., Fox M., Margison G.P. The in vitro lifespan of MRC-5 cells is shortened by 5-azacytidine-induced demethylation. Exp. Cell Res. 168:1987;153-159.
42. Venable M.E., Lee J.Y., Smyth M.J., Bielawska A., Obeid L.M. Role of ceramide in cellular senescence. J. Biol. Chem. 270:1995;30701-30708.
43. Ogryzko V.V., Hirai T.H., Russanova V.R., Barbie D.A., Howard B.H. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent. Mol. Cell. Biol. 16:1996;5210-5218.
44. Chen Q., Ames B.N. Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA. 91:1994;4130-4134.
45. Chen Q., Fischer A., Reagan J.D., Yan L.J., Ames B.N. Oxidative DNA damage and senescence of human diploid fibroblast cells. Proc. Natl. Acad. Sci. USA. 92:1995;4337-4341.
46. Vojta P.J., Barrett J.C. Genetic analysis of cellular senescence. Biochim. Biophys. Acta. 1242:1995;29-41.
47. Tsai K.J., Hung I.J., Chow C.K., Stern A., Chao S.S., Chiu D.T.Y. Impaired production of nitric oxide, superoxide, and hydrogen peroxide in glucose-6-phosphate dehydrogenase-deficient granulocytes. FEBS Lett. 436:1998;411-414.